肛门癌

UKCCCR Anal Cancer Trial Working Party. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet. 1996;348:1049-1054.

• 摘要

Northover J, Glynne-Jones R, Sebag-Montefiore D, et al. Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I). Br J Cancer. 2010;102:1123-1128.

• 摘要

Bartelink H, Roelofsen F, Eschwege F, et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer radiotherapy and gastrointestinal cooperative groups. J Clin Oncol. 1997;15:2040-2049.

• 摘要

Peiffert D, Tournier-Rangeard L, Gérard JP, et al. Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trial. J Clin Oncol. 2012;30:1941-1948.

• 摘要

Flam M, John M, Pajak TF, et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol. 1996;14:2527-2539.

• 摘要

Gunderson LL, Winter KA, Ajani JA, et al. Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin. J Clin Oncol. 2012;30:4344-4351.

• 摘要

James RD, Glynne-Jones R, Meadows HM, et al. Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial. Lancet Oncol. 2013;14:516-524.

• 摘要

John M, Pajak T, Flam M, et al. Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92-08. Cancer J Sci Am. 1996;2:205-211.

• 摘要

Martenson JA, Lipsitz SR, Wagner H Jr, et al. Initial results of a phase II trial of high dose radiation therapy, 5-fluorouracil, and cisplatin for patients with anal cancer (E4292): an Eastern Cooperative Oncology Group study. Int J Radiat Oncol Biol Phys. 1996;35:745-749.

• 摘要

Allal AS, Mermillod B, Roth AD, et al. The impact of treatment factors on local control in T2-T3 anal carcinomas treated by radiotherapy with or without chemotherapy. Cancer. 1997;79:2329-2335.

• 全文
• 摘要

1.  Peters RK, Mack TM. Patterns of anal carcinoma by gender and marital status in Los Angeles County. Br J Cancer. 1983;48:629-636.

• 摘要

2.  Das P, Bhatia S, Eng C, et al. Predictors and patterns of recurrence after definitive chemoradiation for anal cancer. Int J Radiat Oncol Biol Phys. 2007;68:794-800.

• 摘要

3.  Edge SB, Byrd DR, Compton CC, et al., eds; American Joint Committee on Cancer. Anus. In: AJCC cancer staging manual. 7th ed. New York, NY: Springer; 2010:165-173.

4.  Beal KP, Wong D, Guillem JG, et al. Primary adenocarcinoma of the anus treated with combined modality therapy. Dis Colon Rectum. 2003;46:1320-1324.

• 摘要

5.  Siegel R, Ward E, Brawley O, et al. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61:212-236.

• 全文
• 摘要

6.  Association of Coloproctology of Great Britain and Ireland. Guidelines for the management of colorectal cancer. 3rd ed. London, UK: Association of Coloproctology of Great Britain and Ireland; 2007.

7.  Frisch M, Fenger C, van den Brule AJ, et al. Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomaviruses. Cancer Res. 1999;59:753-757.

• 全文
• 摘要

8.  Melbye M, Cote T, Kessler L, et al. High incidence of anal cancer among AIDS patients. Lancet. 1994;343:636-639.

• 摘要

9.  Palefsky JM, Holly EA, Efirdc J, et al. Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men. AIDS. 2005;19:1407-1414.

• 摘要

10.  Aigner F, Boeckle E, Albright J, et al. Malignancies of the colorectum and anus in solid organ recipients. Transpl Int. 2007;20:497-504.

• 摘要

11.  Shepherd NA. Anal intraepithelial neoplasia and other neoplastic precursor lesions of the anal canal and perianal region. Gastroenterol Clin North Am. 2007;36:969-987.

• 摘要

12.  Nahas CS, Lin O, Weiser MR, et al. Prevalence of perianal intraepithelial neoplasia in HIV-infected patients referred for high-resolution anoscopy. Dis Colon Rectum. 2006;49:1581-1586.

• 摘要

13.  Palefsky JM, Giuliano AR, Goldstone S, et al. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med. 2011;365:1576-1585.

• 全文
• 摘要

14.  Buckwalter JA, Jurayj MN. Relationship of chronic anorectal disease to carcinoma. Arch Surg. 1957;75:352-360.

• 摘要

15.  Lin AY, Gridley G, Tucker M. Benign anal lesions and cancer. N Engl J Med. 1995;332:190-191.

• 摘要

16.  Frisch M, Olsen JH, Bautz, A, et al. Benign anal lesions and the risk of anal cancer. N Engl J Med. 1994;331:300-302.

• 摘要

17.  Holly EA, Whittemore AS, Aston DA, et al. Anal cancer incidence: genital warts, anal fissure, hemorrhoids, and smoking. J Natl Cancer Inst. 1989;81:1726-1730.

• 摘要

18.  Petrosky E, Bocchini JA Jr, Hariri S, et al; Centers for Disease Control and Prevention (CDC). Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2015;64:300-304.

• 全文
• 摘要

19.  Bannas P, Weber C, Adam G, et al. Contrast-enhanced [(18)F]fluorodeoxyglucose-positron emission tomography/computed tomography for staging and radiotherapy planning in patients with anal cancer. Int J Radiat Oncol Biol Phys. 2011;81:445-451.

• 摘要

20.  Berard P, Papillon J. Role of pre-operative irradiation for anal preservation in cancer of the low rectum. World J Surg. 1992;16:502-509.

• 摘要

21.  Gerard JP, Ayzac L, Hun D, et al. Treatment of anal canal carcinoma with high dose radiation therapy and concomitant fluorouracil-cisplatinum: long term results in 95 patients. Radiother Oncol. 1998;46:249-256.

• 摘要

22.  Minsky BD, Welton ML, Pineda CE, et al. Cancer of the anal canal. In: Hoppe R, Phillips TL, Roche M, eds. Leibel and Phillips textbook of radiation oncology. 3rd ed. Philadelphia, PA: Elsevier; 2010:870-882.

23.  UKCCCR Anal Cancer Trial Working Party. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet. 1996;348:1049-1054.

• 摘要

24.  Northover J, Glynne-Jones R, Sebag-Montefiore D, et al. Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I). Br J Cancer. 2010;102:1123-1128.

• 摘要

25.  Bartelink H, Roelofsen F, Eschwege F, et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer radiotherapy and gastrointestinal cooperative groups. J Clin Oncol. 1997;15:2040-2049.

• 摘要

26.  Glynne-Jones R, Lim F. Anal cancer: an examination of radiotherapy strategies. Int J Radiat Oncol Biol Phys. 2011;79:1290-1301.

• 摘要

27.  Peiffert D, Tournier-Rangeard L, Gérard JP, et al. Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trial. J Clin Oncol. 2012;30:1941-1948.

• 摘要

28.  Flam M, John M, Pajak TF, et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol. 1996;14:2527-2539.

• 摘要

29.  Gunderson LL, Winter KA, Ajani JA, et al. Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin. J Clin Oncol. 2012;30:4344-4351.

• 摘要

30.  James RD, Glynne-Jones R, Meadows HM, et al. Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial. Lancet Oncol. 2013;14:516-524.

• 摘要

31.  Wexler A, Berson AM, Goldstone SE, et al. Invasive anal squamous-cell carcinoma in the HIV-positive patient: outcome in the era of highly active antiretroviral therapy. Dis Colon Rectum. 2008;51:73-81.

• 摘要

32.  Edelman S, Johnstone PA. Combined modality therapy for HIV-infected patients with squamous cell carcinoma of the anus: outcomes and toxicities. Int J Radiat Oncol Biol Phys. 2006;66:206-211.

• 摘要

33.  Bazan JG, Hara W, Hsu A, et al. Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal. Cancer. 2011;117:3342-3351.

• 摘要

34.  Salama JK, Mell LK, Schomas DA, et al. Concurrent chemotherapy and intensity-modulated radiation therapy for anal cancer patients: a multicenter experience. J Clin Oncol. 2007;25:4581-4586.

• 全文
• 摘要

35.  Kacknic LA, Campbell MP, Lordick F, et al. Two-year outcomes of RTOG 0529: a phase II evaluation of dose-painted IMRT in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal. J Clin Oncol. 2011;29(suppl 4):abstr 368.

• 全文

36.  Ben-Joseph E, Moughan J, Ajani JA, et al. Impact of overall treatment time on survival and local control in patients with anal cancer: a pooled data analysis of Radiation Therapy Oncology Group trials 87-04 and 98-11. J Clin Oncol. 2010;28:5061-5066.

• 摘要

37.  Hung A, Crane CH, Delclos M, et al. Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic index. Cancer. 2003;97:1195-1202.

• 全文
• 摘要

38.  Phan LK, Hoff PM. Evidence of clinical activity for cetuximab combined with irinotecan in a patient with refractory anal canal squamous-cell carcinoma: report of a case. Dis Colon Rectum. 2007;50:395-398.

• 摘要

39.  John M, Pajak T, Flam M, et al. Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92-08. Cancer J Sci Am. 1996;2:205-211.

• 摘要

40.  Martenson JA, Lipsitz SR, Wagner H Jr, et al. Initial results of a phase II trial of high dose radiation therapy, 5-fluorouracil, and cisplatin for patients with anal cancer (E4292): an Eastern Cooperative Oncology Group study. Int J Radiat Oncol Biol Phys. 1996;35:745-749.

• 摘要

41.  Peiffert D, Bey P, Pernot M, et al. Conservative management by irradiation of epidermoid cancers of the anal canal: prognostic factors of tumor control and complications. Int J Radiat Oncol Biol Phys. 1997;37:313-324.

• 摘要

42.  Cummings BJ, Keane TJ, O'Sullivan B, et al. Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin-C. Int J Radiat Oncol Biol Phys. 1991;21:1115-1125.

• 摘要

43.  Allal AS, Mermillod B, Roth AD, et al. The impact of treatment factors on local control in T2-T3 anal carcinomas treated by radiotherapy with or without chemotherapy. Cancer. 1997;79:2329-2335.

• 全文
• 摘要

44.  Kapp KS, Geyer E, Gebhart FH, et al. Evaluation of sphincter function after external beam irradiation and Ir-192 high-dose-rate (HDR) brachytherapy +/- chemotherapy in patients with carcinoma of the anal canal. Int J Radiat Oncol Biol Phys. 1999;45:339.

45.  Tournier-Rangeard L, Mercier M, Peiffert D, et al. Radiochemotherapy of locally advanced anal canal carcinoma: prospective assessment of early impact on the quality of life (randomized trial ACCORD 03). Radiother Oncol. 2008;87:391-397.

• 摘要

46.  Weber DC, Nouet P, Kurtz JM, et al. Assessment of target dose delivery in anal cancer using in vivo thermoluminescent dosimetry. Radiother Oncol. 2001;59:39-43.

• 摘要

47.  Christensen AF, Nielsen MB, Svendsen LB, et al. Three-dimensional anal endosonography may improve detection of recurrent anal cancer. Dis Colon Rectum. 2006;49:1527-1532.

• 摘要

48.  Petrelli NJ, Palmer M, Herrera L. The utility of squamous cell carcinoma antigen for the follow-up of patients with squamous cell carcinoma of the anal canal. Cancer. 1992;70:35-39.

• 摘要